as 01-17-2025 4:00pm EST
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
Founded: | 1971 | Country: | United States |
Employees: | N/A | City: | BURLINGTON |
Market Cap: | 19.2B | IPO Year: | N/A |
Target Price: | $260.07 | AVG Volume (30 days): | 531.6K |
Analyst Decision: | Buy | Number of Analysts: | 16 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 5.14 | EPS Growth: | -31.25 |
52 Week Low/High: | $191.97 - $247.99 | Next Earning Date: | 02-06-2025 |
Revenue: | $12,712,800,000 | Revenue Growth: | 5.43% |
Revenue Growth (this year): | 9.99% | Revenue Growth (next year): | 6.22% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
EISENBERG GLENN A | LH | Executive Vice President | Dec 2 '24 | Sell | $240.43 | 11,711 | $2,815,651.14 | 31,289 | |
Gilliland Dwight Gary | LH | Director | Dec 2 '24 | Sell | $241.00 | 1,000 | $241,000.00 | 7,712 | |
Schechter Adam H | LH | President & CEO | Nov 11 '24 | Sell | $243.47 | 6,189 | $1,506,835.83 | 87,441 | |
ANDERSON KERRII B | LH | Director | Oct 24 '24 | Sell | $230.00 | 1,000 | $230,000.00 | 13,722 |
LH Breaking Stock News: Dive into LH Ticker-Specific Updates for Smart Investing
Simply Wall St.
6 days ago
PR Newswire
8 days ago
Zacks
9 days ago
PR Newswire
10 days ago
PR Newswire
10 days ago
Zacks
15 days ago
Zacks
16 days ago
Zacks
23 days ago
The information presented on this page, "LH Laboratory Corporation of America Holdings - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.